RecruitingNCT06562140

Multidimensional Examination of Patients with Colorectal and Anal Cancer

Multidimensional Examination of Physical Activity, Functional Capacity, and Health Status in Patients with Colorectal and Anal Cancer

Sponsor

University of Pecs

Enrollment

300 participants

Start Date

Aug 15, 2024

Study Type

OBSERVATIONAL

Conditions

Colorectal, Cancer Quality of Life Physical Inactivity Anal Cancer Fecal Incontinence

Summary

The aim of our cross-sectional research is to assess changes in physical activity, functional capacity, and health status in individuals with colorectal and anal carcinoma using subjective measurement tools, with particular focus on those suffering from incontinence, through a cross-sectional study. Additionally, the research involves the Hungarian adaptation and validation of the quality of life questionnaire for colorectal cancer (EORTC QLQ-CR29), quality of life questionnaire for anal cancer (EORTC QLQ-AN27), and Fecal Incontinence Severity Index (FISI)" questionnaires.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study performs a thorough, multi-dimensional evaluation of adults with colorectal or anal cancer, assessing them across physical, psychological, functional, and quality-of-life dimensions. The aim is to better understand the full impact of these cancers and their treatments on patients, and to identify measures that could guide more personalized care and support. **You may be eligible if...** - You are an adult aged 18–80 - You have a confirmed diagnosis of colorectal cancer (cancer of the colon or rectum) or anal cancer **You may NOT be eligible if...** - You have a neuromuscular disease or severe congenital musculoskeletal disorder - You have severe psychiatric illness or are unable to cooperate with assessments - You have had another surgical procedure within the past year Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.